MOLN:NASDAQ
Molecular Partners AG
၃.၉၂ US$
arrow_downward
-၆.၆၇%(-၀.၂၈) 1D
စက် ၁၆, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
၃.၈၄ US$
High
၄.၀၂ US$
Low
၃.၈၄ US$
Mkt. cap
၁၅.၅၄ ကုဋေ
Avg. vol.
၁.၁၀ ထောင်
Volume
၁၇.၀၀
52-wk high
၅.၃၆ US$
52-wk low
၃.၅၃ US$
EPS
-၁.၆၇ US$
Beta
၁.၀၂
Shares outstanding
၄.၀၄ ကုဋေ
No. of employees
၁၃၄
Open
၃.၈၄ US$
High
၄.၀၂ US$
Low
၃.၈၄ US$
Mkt. cap
၁၅.၅၄ ကုဋေ
Avg. vol.
၁.၁၀ ထောင်
Volume
၁၇.၀၀
52-wk high
၅.၃၆ US$
52-wk low
၃.၅၃ US$
EPS
-၁.၆၇ US$
Beta
၁.၀၂
Shares outstanding
၄.၀၄ ကုဋေ
No. of employees
၁၃၄
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG